Abstract

Tolerability and outcomes with rollout of tixagevimab-cilgavimab in patients with common variable immunodeficiency

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call